VCEL
insider transactionsVericel Corp — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-34.7K
0 buy · 34.7K sell
Net value · 90d
-$1.2M
$0 in · $1.2M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
9
0 buy · 34.7K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
4.4K sh
Own New
-
Sell·S
Chief Medical Officer · 10b5-1
$153.1K
4.4K sh · $35.00
Own -5%
-
Exercise·M
Chief Medical Officer · 10b5-1
$72.9K
4.4K sh · $16.66
Own +6%
-
Exercise·M
Director · 10b5-1
$0
3.5K sh
Own New
-
Sell·S
Director · 10b5-1
$114.9K
3.5K sh · $32.82
Own -16%
-
Exercise·M
Director · 10b5-1
$45.7K
3.5K sh · $13.05
Own +19%
-
Sell·S
Director · 10b5-1
$114.9K
3.5K sh · $32.83
Own -16%
-
Exercise·M
Director · 10b5-1
$9.2K
3.5K sh · $2.63
Own +19%
-
Sell·S
Director
$244.8K
7.5K sh · $32.64
Own -29%
-
Sell·S
Director
$82.6K
2.5K sh · $33.05
Own -9%
-
Sell·S
Principal Accounting Officer · 10b5-1
$57.6K
1.4K sh · $40.50
Own -56%
-
Sell·S
Chief Financial Officer · 10b5-1
$202.5K
5.0K sh · $40.50
Own -19%
-
Sell·S
Principal Accounting Officer · 10b5-1
$130.5K
3.4K sh · $38.00
Own -57%
-
Grant·A
Director
$0
3.2K sh
Own New
-
Grant·A
Director
$0
8.0K sh
Own New
-
Exercise·M
Director
—
3.2K sh
Own New
-
Exercise·M
Director
—
3.2K sh
Own +12%
-
Grant·A
Director
$0
3.2K sh
Own New
-
Grant·A
Director
$0
8.0K sh
Own New
-
Exercise·M
Director
$0
3.2K sh
Own New
-
Exercise·M
Director
—
3.2K sh
Own +11%
-
Grant·A
Director
$0
3.2K sh
Own New
-
Grant·A
Director
$0
8.0K sh
Own New
-
Exercise·M
Director
—
3.2K sh
Own New
-
Exercise·M
Director
—
3.2K sh
Own +25%
-
Grant·A
Director
$0
3.2K sh
Own New
-
Grant·A
Director
$0
8.0K sh
Own New
-
Exercise·M
Director
$0
3.2K sh
Own New
-
Exercise·M
Director
—
3.2K sh
Own +5%
-
Grant·A
Director
$0
3.2K sh
Own New
-
Grant·A
Director
$0
8.0K sh
Own New
-
Exercise·M
Director
$0
3.2K sh
Own New
-
Exercise·M
Director
—
3.2K sh
Own +21%
-
Grant·A
Director
$0
3.2K sh
Own New
-
Grant·A
Director
$0
8.0K sh
Own New
-
Exercise·M
Director
$0
3.2K sh
Own New
-
Exercise·M
Director
—
3.2K sh
Own +10%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
3.5K sh
Own +61%
-
Sell·S
Chief Medical Officer · 10b5-1
$121.5K
3.5K sh · $35.00
Own -4%
-
Exercise·M
Chief Medical Officer · 10b5-1
$38.0K
3.5K sh · $10.95
Own +5%
-
Exercise·M
Director
$0
15.0K sh
Own New
-
Exercise·M
Director
$41.4K
15.0K sh · $2.76
Own +33%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 2, 2026 | Jonathan Mark Hopper 10b5-1 | Exercise M | 4.4K | $0 |
| Jun 2, 2026 | Jonathan Mark Hopper 10b5-1 | Sell S | 4.4K | $153.1K |
| Jun 2, 2026 | Jonathan Mark Hopper 10b5-1 | Exercise M | 4.4K | $72.9K |
| May 13, 2026 | Kevin F Mclaughlin 10b5-1 | Exercise M | 3.5K | $0 |
| May 13, 2026 | Kevin F Mclaughlin 10b5-1 | Sell S | 3.5K | $114.9K |
| May 13, 2026 | Kevin F Mclaughlin 10b5-1 | Exercise M | 3.5K | $45.7K |
| May 13, 2026 | Kevin F Mclaughlin 10b5-1 | Sell S | 3.5K | $114.9K |
| May 13, 2026 | Kevin F Mclaughlin 10b5-1 | Exercise M | 3.5K | $9.2K |
| May 11, 2026 | Paul K Wotton | Sell S | 7.5K | $244.8K |
| May 11, 2026 | Paul K Wotton | Sell S | 2.5K | $82.6K |
| May 7, 2026 | Jonathan Siegal 10b5-1 | Sell S | 1.4K | $57.6K |
| May 7, 2026 | Joseph Anthony Mara Jr KEY 10b5-1 | Sell S | 5.0K | $202.5K |
| May 6, 2026 | Jonathan Siegal 10b5-1 | Sell S | 3.4K | $130.5K |
| Apr 29, 2026 | Paul K Wotton | Grant A | 3.2K | $0 |
| Apr 29, 2026 | Paul K Wotton | Grant A | 8.0K | $0 |
| Apr 29, 2026 | Paul K Wotton | Exercise M | 3.2K | — |
| Apr 29, 2026 | Paul K Wotton | Exercise M | 3.2K | — |
| Apr 29, 2026 | Robert L Zerbe MD | Grant A | 3.2K | $0 |
| Apr 29, 2026 | Robert L Zerbe MD | Grant A | 8.0K | $0 |
| Apr 29, 2026 | Robert L Zerbe MD | Exercise M | 3.2K | $0 |
| Apr 29, 2026 | Robert L Zerbe MD | Exercise M | 3.2K | — |
| Apr 29, 2026 | Lisa Wright | Grant A | 3.2K | $0 |
| Apr 29, 2026 | Lisa Wright | Grant A | 8.0K | $0 |
| Apr 29, 2026 | Lisa Wright | Exercise M | 3.2K | — |
| Apr 29, 2026 | Lisa Wright | Exercise M | 3.2K | — |
| Apr 29, 2026 | Alan L Rubino | Grant A | 3.2K | $0 |
| Apr 29, 2026 | Alan L Rubino | Grant A | 8.0K | $0 |
| Apr 29, 2026 | Alan L Rubino | Exercise M | 3.2K | $0 |
| Apr 29, 2026 | Alan L Rubino | Exercise M | 3.2K | — |
| Apr 29, 2026 | Kevin F Mclaughlin | Grant A | 3.2K | $0 |
| Apr 29, 2026 | Kevin F Mclaughlin | Grant A | 8.0K | $0 |
| Apr 29, 2026 | Kevin F Mclaughlin | Exercise M | 3.2K | $0 |
| Apr 29, 2026 | Kevin F Mclaughlin | Exercise M | 3.2K | — |
| Apr 29, 2026 | Heidi Hagen | Grant A | 3.2K | $0 |
| Apr 29, 2026 | Heidi Hagen | Grant A | 8.0K | $0 |
| Apr 29, 2026 | Heidi Hagen | Exercise M | 3.2K | $0 |
| Apr 29, 2026 | Heidi Hagen | Exercise M | 3.2K | — |
| Apr 2, 2026 | Jonathan Mark Hopper 10b5-1 | Exercise M | 3.5K | $0 |
| Apr 2, 2026 | Jonathan Mark Hopper 10b5-1 | Sell S | 3.5K | $121.5K |
| Apr 2, 2026 | Jonathan Mark Hopper 10b5-1 | Exercise M | 3.5K | $38.0K |
| Mar 25, 2026 | Alan L Rubino | Exercise M | 15.0K | $0 |
| Mar 25, 2026 | Alan L Rubino | Exercise M | 15.0K | $41.4K |
About VCEL insider trading
This page tracks insider transactions for Vericel Corp (VCEL) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.